Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-04-27 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CASSEL (59670), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU MONT CASSEL : revenue, balance sheet and financial ratios
PHARMACIE DU MONT CASSEL is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CASSEL (59670),
this company of category PME
shows in 2023 a net income positive of 51 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU MONT CASSEL (SIREN 811085083)
Indicator
2023
2022
2021
2020
2019
2018
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
51 483 €
163 841 €
212 602 €
138 038 €
143 897 €
168 276 €
79 491 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DU MONT CASSEL generates positive net income of 51 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 79 k€ -> 51 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
51 483 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 114%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
113.777%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.249%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU MONT CASSEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2022
2023
Debt ratio
283.634
310.525
213.334
164.861
113.817
133.466
113.777
Financial autonomy
24.211
21.957
28.906
33.703
41.685
37.866
41.249
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
113.782023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average+6 pts over 3 years
In 2023, the debt ratio of PHARMACIE DU MONT CASSEL (113.78) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.25%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average-6 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DU MONT CASSEL (41.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 265.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
265.77
Liquidity indicators evolution PHARMACIE DU MONT CASSEL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2021
2022
2023
Liquidity ratio
319.219
262.502
247.045
241.271
257.979
283.957
265.77
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
265.772023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good
In 2023, the liquidity ratio of PHARMACIE DU MONT CASSEL (265.77) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DU MONT CASSEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DU MONT CASSEL is estimated at
607 472 €
(range 369 433€ - 853 969€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
369k€607k€853k€
607 472 €Range: 369 433€ - 853 969€
NAF 5 année 2023
Valuation method used
Net Income Multiple
51 483 €
×
11.8x
=607 472 €
Range: 369 433€ - 853 970€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU MONT CASSEL with other companies in the same sector:
Frequently asked questions about PHARMACIE DU MONT CASSEL
What is the revenue of PHARMACIE DU MONT CASSEL ?
The revenue of PHARMACIE DU MONT CASSEL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU MONT CASSEL profitable?
Yes, PHARMACIE DU MONT CASSEL generated a net profit of 51 k€ in 2023.
Where is the headquarters of PHARMACIE DU MONT CASSEL ?
The headquarters of PHARMACIE DU MONT CASSEL is located in CASSEL (59670), in the department Nord.
Where to find the tax return of PHARMACIE DU MONT CASSEL ?
The tax return of PHARMACIE DU MONT CASSEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU MONT CASSEL operate?
PHARMACIE DU MONT CASSEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart